Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study-Reference-Cited by-同舟云学术

Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study

Published:2017-10-09 Issue:10 Volume:57 Page:1507-1521
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Lipton Richard B.¹²,Reed Michael L.³,Kurth Tobias⁴,Fanning Kristina M.³,Buse Dawn C.¹

Affiliation:

1. Department of Neurology; Albert Einstein College of Medicine and Montefiore Headache Center; Bronx NY (Richard B. Lipton and Dawn C. Buse)

2. Department of Epidemiology and Population Health; Albert Einstein College of Medicine; Bronx NY (Richard B. Lipton)

3. Vedanta Research; Chapel Hill NC (Michael L. Reed and Kristina M. Fanning)

4. Institute of Public Health; Charité - Universitätsmedizin Berlin; Germany (Tobias Kurth)

Funder

The American Migraine Prevalence and Prevention (AMPP) Study

National Hemophilia Foundation

McNeil-Janssen Scientific Affairs (MJSA) LLC, Raritan, NJ

Merck & Co. (Kenilworth, NJ)

CoLucid Pharmaceuticals (Cambridge, MA)

Eli Lilly and Company (Indianapolis, Indiana)

National Headache Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.13179/fullpdf

Reference36 articles.

1. Migraine and risk of cardiovascular disease in men;Kurth;Arch Intern Med.,2007

2. Migraine and risk of cardiovascular disease in women;Kurth;JAMA.,2006

3. Migraine and cardiovascular disease: Systematic review and meta-analysis;Schürks;BMJ.,2009

4. Triptan use as a function of cardiovascular risk. A population-based study;Bigal;Headache.,2010

5. Migraine and cardiovascular disease: A population-based study;Bigal;Neurology.,2010

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

2. Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study;Cephalalgia;2024-08

3. Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine;Headache: The Journal of Head and Face Pain;2024-05-27

4. Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK;Journal of Medical Economics;2024-04-27

5. Acute Treatment of Migraine;CONTINUUM: Lifelong Learning in Neurology;2024-04